Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)
Stopped Interim analysis concluded to futility of main study SIDEROS (SNT-III-012)
Conditions
- Duchenne Muscular Dystrophy
Interventions
- DRUG: idebenone 150 mg film-coated tablets
Sponsor
Santhera Pharmaceuticals